Non-peptidic δ opioid receptor agonists and antagonists (2000 – 2012)

Author： Fujii Hideaki   Takahashi Toshihiro   Nagase Hiroshi  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.9, 2013-09, pp. : 1181-1208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel developments with selective, non-peptidic kappa-opioid receptor agonists

By Barber A.   Gottschlich R.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 10, 1997-10 ,pp. : 1351-1368

Informa Healthcare

Access to resources Recommend Favorite

Non-Peptidic GnRH Receptor Antagonists

By  

Current Medicinal Chemistry, Vol. 11, Iss. 22, 2004-11 ,pp. : 3017-3028

Bentham Science Publishers

Access to resources Recommend Favorite

Antinociceptive effects of the selective non-peptidic -opioid receptor agonist TAN-67 in diabetic mice

By Kamei J.   Saitoh A.   Ohsawa M.   Suzuki T.   Misawa M.   Nagase H.   Kasuya Y.  

European Journal of Pharmacology, Vol. 276, Iss. 1, 1995-03 ,pp. : 131-135

Elsevier

Access to resources Recommend Favorite

Non-Peptidic CRF1 Receptor Antagonists for the Treatment of Anxiety,Depression and Stress Disorders

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 5, 2002-10 ,pp. : 467-493

Bentham Science Publishers

Access to resources Recommend Favorite

Non-peptide &dgr; opioid agonists and antagonists

By Dondio G.   Ronzoni S.   Petrillo P.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1075-1098

Informa Healthcare

Access to resources Recommend Favorite